secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001477932-23-007528
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health reports H1 2023 adjusted net income $3.01M, issues 2026 guidance of $180M revenue
--------------------------------------------------------------------------------

- H1 2023 Adjusted EBITDA of $3.01M (up 182% YoY) and Adjusted Net Income of $3.01M (up from -$0.09M loss).
- Inaugural 2026 guidance: gross annual revenue exceeding $180M and EBITDA >$20M.
- Completed three acquisitions in 2023: Cana Laboratories, Bikas GP (adds >$10M annual revenue), and ZipDoctor.
- Book value per share >$4 (2.5x current price); unencumbered properties fair value >$12M (>50% market cap).
- CEO Greg Siokas invested >$15M total, ~$850K YTD; share buyback up to $3M started Sept 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223007528/0001477932-23-007528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223007528/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-007528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer